Variant report
Variant | esv3404586 |
---|---|
Chromosome Location | chr4:81823128-81824326 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs372189057 | chr4:81823167-81823168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs182116674 | chr4:81823175-81823176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543710632 | chr4:81823192-81823193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs563687045 | chr4:81823209-81823210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs529554140 | chr4:81823211-81823212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553113787 | chr4:81823214-81823215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548109867 | chr4:81823281-81823282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs377035330 | chr4:81823291-81823292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187036554 | chr4:81823311-81823312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs191517251 | chr4:81823314-81823315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs528215379 | chr4:81823366-81823367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185453594 | chr4:81823474-81823475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs4992615 | chr4:81823512-81823513 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs4992616 | chr4:81823524-81823525 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs534024749 | chr4:81823539-81823540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188369978 | chr4:81823564-81823565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs199556337 | chr4:81823572-81823573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs372460204 | chr4:81823577-81823578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs199802331 | chr4:81823602-81823603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs374147096 | chr4:81823612-81823613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs553159710 | chr4:81823613-81823614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs144776079 | chr4:81823616-81823617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs374886123 | chr4:81823618-81823619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs370560197 | chr4:81823620-81823621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs373730247 | chr4:81823627-81823628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs367721659 | chr4:81823628-81823629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs13116671 | chr4:81823629-81823630 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs9714558 | chr4:81823630-81823631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs201644522 | chr4:81823635-81823636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs9714875 | chr4:81823636-81823637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs7440444 | chr4:81823637-81823638 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs9714559 | chr4:81823638-81823639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs193279751 | chr4:81823642-81823643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372112784 | chr4:81823645-81823646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs374653143 | chr4:81823646-81823647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs372604502 | chr4:81823734-81823735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs370673737 | chr4:81823740-81823741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs376871371 | chr4:81823741-81823742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs185486184 | chr4:81823742-81823743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs368258035 | chr4:81823744-81823745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs3038572 | chr4:81823780-81823781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs563329694 | chr4:81823796-81823797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs16998370 | chr4:81823811-81823812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542926679 | chr4:81823837-81823838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs151052599 | chr4:81823906-81823907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs373429062 | chr4:81823948-81823949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs528634886 | chr4:81823989-81823990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs140026603 | chr4:81824057-81824058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs143558762 | chr4:81824067-81824068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs576794395 | chr4:81824139-81824140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Gastric cancer | 16891809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:81822400-81823600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr4:81823600-81825000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |